SIKLOS Film-coated tablet Ref.[7540] Active ingredients: Hydroxycarbamide

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: Addmedica, 37 rue de Caumartin, 75009 Paris, France, Phone: +33 1 72 69 01 86, Fax: +33 1 73 72 94 13, E-mail: contact@addmedica.com

Product name and form

Siklos 100 mg film-coated tablets.

Siklos 1000 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Siklos 100 mg film-coated tablets: Off-white oblong-shaped, film-coated tablet with half-scoring on both sides. The tablet can be divided into two equal parts. Each half of tablet is embossed “H” on one side.

Siklos 1000 mg film-coated tablets: Off-white, capsule-shaped, film-coated tablet with triple scoring on both sides. The tablet can be divided into four equal parts. Each quarter of tablet is embossed “T” on one side.

Qualitative and quantitative composition

Siklos 100 mg film-coated tablets: Each film-coated tablet contains 100 mg of hydroxycarbamide.

Siklos 1000 mg film-coated tablets: Each film-coated tablet contains 1,000 mg of hydroxycarbamide.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Hydroxycarbamide

One of the mechanisms by which hydroxycarbamide acts is the elevation of foetal haemoglobin (HbF) concentrations in sickle cell patients. In addition hydroxycarbamide causes an immediate inhibition of DNA synthesis by acting as a ribonucleotide reductase inhibitor, without interfering with the synthesis of ribonucleic acid or protein.

List of Excipients

Sodium stearyl fumarate
Silicified microcrystalline cellulose
Basic butylated methacrylate copolymer

Pack sizes and marketing

High density polyethylene (HDPE) bottle with polypropylene child-resistant closure with a dessicant unit.

Siklos 100 mg film-coated tablets: Pack sizes of 60, 90 or 120 tablets.

Not all pack sizes may be marketed.

Siklos 1000 mg film-coated tablets: Pack size of 30 tablets.

Marketing authorization holder

Addmedica, 37 rue de Caumartin, 75009 Paris, France, Phone: +33 1 72 69 01 86, Fax: +33 1 73 72 94 13, E-mail: contact@addmedica.com

Marketing authorization dates and numbers

Siklos 100 mg film-coated tablets:

EU/1/07/397/002
EU/1/07/397/003
EU/1/07/397/004

Siklos 1000 mg film-coated tablets:

EU/1/07/397/001

Date of first authorisation: 29/06/2007
Date of latest renewal: 24/04/2017

Drugs

Drug Countries
SIKLOS Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.